Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

NeurogesX Reports First Quarter 2012 Results
Yahoo
Friday, May 4, 2012 - 10:44am
tags:
earnings, NeurogesX
Warner Chilcott cuts full-year forecast
Reuters
Friday, May 4, 2012 - 10:44am
tags:
earnings, guidance, Warner Chilcott
MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results
Yahoo
Friday, May 4, 2012 - 10:43am
tags:
earnings, MAP Pharmaceuticals
FDA declines to approve Alexza's schizophrenia drug
Reuters
Friday, May 4, 2012 - 10:42am
tags:
schizophrenia, FDA, Alexza, Adasuve
Should the FDA Approve More Drugs after Phase II?
Forbes
Friday, May 4, 2012 - 10:42am
tags:
FDA, drug approvals
Pfizer's Lyrica falls short in two pain studies
Reuters
Friday, May 4, 2012 - 10:41am
tags:
Pfizer, Lyrica, HIV, nerve pain, diabetes
Diving for Dividend Growth in Big Pharma
Motley Fool
Friday, May 4, 2012 - 10:40am
tags:
dividends, GSK, Novartis, AstraZeneca, Sanofi, Abbott Laboratories, Roche, Bayer
Will the FDA Approve Alexza's Adasuve?
Motley Fool
Thursday, May 3, 2012 - 4:49pm
tags:
FDA, Alexza, Adasuve, antipsychotics, Pfizer, Bristol-Myers Squibb, Eli Lilly
Top 10 Pharma CEO Salaries of 2011
Fierce Pharma
Thursday, May 3, 2012 - 4:47pm
tags:
executive pay, Pharma CEOs
Repligen Corp Earnings: Significant Revenue Growth
Wall St. Cheat Sheet
Thursday, May 3, 2012 - 12:09pm
tags:
Repligen, earnings
Eli Lilly Paying Investors To Wait
Investopedia.com
Thursday, May 3, 2012 - 12:08pm
tags:
investors, Eli Lilly
U.S. to partner with Big Pharma for drug discovery
Reuters
Thursday, May 3, 2012 - 12:07pm
tags:
US Government, Big Pharma, Pfizer, AstraZeneca, Eli Lilly
3 High-Growth Biotech Stocks With Bearish Short Trends
Seeking Alpha
Thursday, May 3, 2012 - 11:20am
tags:
Arena Pharmaceuticals, Xoma, Vivus
Testosterone Chases Viagra in Libido Race as Doctors Fret
Bloomberg
Thursday, May 3, 2012 - 11:11am
tags:
Viagra, testosterone, Eli Lilly, Axiron, Androgel, Abbott Laboratories
Synergy's Appointment Of Former Pfizer Manager Points To Takeover Potential
Seeking Alpha
Thursday, May 3, 2012 - 11:05am
tags:
Pfizer, M&A, Synergy Pharmaceuticals, Abbott Laboratories, Ironwood
Abbott, Biocon to develop nutrition products for India
Reuters
Thursday, May 3, 2012 - 11:03am
tags:
India, nutrition, Biocon, Abbott Laboratories
GSK rejects idea of buying AstraZeneca
Reuters
Thursday, May 3, 2012 - 11:00am
tags:
GSK, AstraZeneca, M&A
YM Biosciences: The Next Way To Get Long Myelofibrosis
Seeking Alpha
Thursday, May 3, 2012 - 10:58am
tags:
YM BioSciences, myelofibrosis, Novartis, Eli Lilly, Incyte, CYT387
Abbott to acquire Action Pharma's AP214 investigational compound
The Fly on the Wall
Thursday, May 3, 2012 - 10:56am
tags:
Abbott Laboratories, Action Pharma, AP214
Why These 2 Biotechs Are Soaring
Motley Fool
Thursday, May 3, 2012 - 10:55am
tags:
Amarin, Regeneron

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.